Skip to main content
Log in

Chronic α1 blockade in a patient with Eisenmenger syndromeblockade in a patient with Eisenmenger syndrome

  • Case Reports
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Summary

In an 18-year-old male with Eisenmenger syndrome cyanosis and erythrocytosis were increasing. The erythrocytosis diminished following oral bunazosin and phlebotomy was not needed during the treatment. When bunazosin was stopped, the erythrocytosis increased, but when it was resumed, the erythrocytosis and general fatigue diminished.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cottrell AJ, Pearson DT, Hunter S (1982) Alpha blockade in pulmonary hypertension [Letter].Pediatr Cardiol 2:89–90

    PubMed  Google Scholar 

  2. Fiber MA, Colucci WS, Lorell BH (1985) Inotropic vascular and neuroendocrine effects of nifedipine in heart failure: Comparison with nitroprusside.J Am Coll Cardiol 5:731–737

    PubMed  Google Scholar 

  3. Gardin JM, Davidson DM, Rohan MK, Butman S, Knoll M, Garcia S, Gardin SK, Henry WL (1987) Relationship between age, body size, gender, and blood pressure and Doppler flow measurements in aorta and pulmonary artery.Am Heart J 113:101–109

    Article  PubMed  Google Scholar 

  4. Kitabatake A, Inoue M, Asano M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H (1983) Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique.Circulation 68:302–309

    PubMed  Google Scholar 

  5. Itoh K, Kohya T, Nishijima H, Minami S, Tsujinaga H, Yasuda H (1983) Acute effect of new α1 blocking drug, E-643 in severe congestive heart failure—Pharmacokinetic and hemodynamics.Kokyuto Junkan 31:1117–1121

    Google Scholar 

  6. Murray TS, Langan J, Coxhead PF (1986) Long-term effects of nicardipine in the treatment of essential hypertension.Br J Clin Pharmacol 22:249s-257s

    Google Scholar 

  7. Packer M (1985) Vasodilator therapy for primary pulmonary hypertension.Ann Intern Med 103:258–270

    PubMed  Google Scholar 

  8. Rich S, Hart K, Kierask K (1987) Thromboxane synthetase inhibition in primary pulmonary hypertension.Chest 91:356–360

    PubMed  Google Scholar 

  9. Sandor GGS (1984) Clinical and echocardiographic evidence suggesting afterload reduction as a mechanism of tolazoline in neonatal hypoxia.Pediatr Cardiol 5:93

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Watanabe, K., Mori, C., Haneda, N. et al. Chronic α1 blockade in a patient with Eisenmenger syndromeblockade in a patient with Eisenmenger syndrome. Pediatr Cardiol 12, 52–53 (1991). https://doi.org/10.1007/BF02238502

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02238502

Key Words

Navigation